Ashland appoints Merck EVP Sanat Chattopadhyay to board; two directors not seeking re-election

ASHLAND INC.

Sanat Chattopadhyay, executive vice president of Merck (MRK), joined Ashland board effective Nov. 13, 2023.
Chattopadhyay serves on Environmental, Health, Safety, and Quality and Governance and Nominating Committees.
Directors Jay V. Ihlenfeld and Brendan M. Cummins will not stand for re-election at January 2024 annual meeting.
Board temporarily expands to 11 members until the 2024 annual meeting.
Chattopadhyay brings experience in biopharma operations, manufacturing, and global supply chain.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Sanat Chattopadhyay

Director

ASH · ASHLAND INC.

Effective: 2023-11-13
Filed: November 14, 2023, 6:59 PM ET

On November 13, 2023, the Board of Directors (“Board”) of Ashland Inc. (“Company”) elected Sanat Chattopadhyay to the Board to serve as an independent director

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Sanat Chattopadhyay was elected as Director at ASHLAND INC..

Action: elected
Role: Director

Exact text from the filing

On November 13, 2023, the Board of Directors (“Board”) of Ashland Inc. (“Company”) elected Sanat Chattopadhyay to the Board to serve as an independent director

View on SEC.gov

ASHLAND INC. filing history →

Source: SEC EDGAR

accession 0000950170-23-063863

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.